Biotech · Public company · Cambridge, MA, US
Scholar Rock Holding Corp
Ticker SRRK · SEC CIK 0001727196
Track this companyFree. Adds Scholar Rock Holding Corp to your Dealase workspace and tells you when its record changes.
Clinical trials84 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline10
- ApitegromabPhase 3 · Spinal Muscular AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- ApitegromabPhase 2 · Facioscapulohumeral Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- ApitegromabPhase 2 · Overweight and ObesityClinicalTrials.gov · fetched Nov 12, 2026
- NusinersenPhase 2 · Spinal Muscular AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- RisdiplamPhase 2 · Spinal Muscular AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- SRK-015Phase 2 · Spinal Muscular AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- TirzepatidePhase 2 · Overweight and ObesityClinicalTrials.gov · fetched Nov 12, 2026
- anti-PD-(L)1 antibody therapyPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- SRK-181Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- SRK-439Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Phase 2 Study Evaluating Apitegromab for the Treatment of FSHDPHASE2 · RECRUITING · started Jul 30, 2026ClinicalTrials.gov NCT07435129 · fetched Nov 12, 2026
- A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy AdultsPHASE1 · RECRUITING · started Nov 21, 2025ClinicalTrials.gov NCT07444294 · fetched Nov 12, 2026
- A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyPHASE2 · RECRUITING · started Sep 15, 2025ClinicalTrials.gov NCT07047144 · fetched Nov 12, 2026
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObesePHASE2 · COMPLETED · started May 21, 2024ClinicalTrials.gov NCT06445075 · fetched Nov 12, 2026
- Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 17, 2023ClinicalTrials.gov NCT05626855 · fetched Nov 12, 2026
- Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or RisdiplamPHASE3 · COMPLETED · started Apr 14, 2022ClinicalTrials.gov NCT05156320 · fetched Nov 12, 2026
- SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)PHASE1 · COMPLETED · started Apr 23, 2020ClinicalTrials.gov NCT04291079 · fetched Nov 12, 2026
- An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyPHASE2 · COMPLETED · started Apr 22, 2019ClinicalTrials.gov NCT03921528 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 15, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026